Loading stock data…
AMWL
$8.50-0.25 (-2.86%)
After Hours$8.50+0.00 (+0.00%)· Last close Jun 9
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
American Well Corporation in the Healthcare sector is trading at $8.50 with a market capitalization of $141M. Wall Street consensus targets $7.50 (5 analysts), implying a -11.8% move over the next 12 months. The stock is currently 15% below its 52-week high of $9.96, remaining 48.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -11.8% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$8.50
Potential Downside
0%
Whystock Fair Value$8.50
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Hold
Mean target$7.50-11.8%
Range$6.50 – $9.00
Fundamentals
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scala...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$141.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.53
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-38.66%
Volume
Today's trading volume
118,704
Recent News
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
Here is how Butterfly Network, Inc. (BFLY) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Shifting Narrative For American Well (AMWL) As Analysts Debate The New US$7.50 Target
American Well’s latest analyst update centers on a higher price target, with fair value moving from US$6.25 to US$7.50 per share. Bulls see this new US$7.50 mark as better aligned with refreshed assumptions, while bears argue it leans heavily on forecasts that may prove optimistic. As you read on, you will see how this evolving price target story can shape the way you track the stock’s changing narrative. Stay updated as the Fair Value for American Well shifts by adding it to your watchlist...
Hims & Hers Expands Digital Healthcare Platform via New Care Offerings
HIMS broadens its digital health platform with Labs, menopause and testosterone care, global acquisitions and a Novo Nordisk GLP-1 tie-up.
American Well (AMWL) Upgraded to Buy: Here's What You Should Know
American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).